Loading clinical trials...
Loading clinical trials...
Interventional, Open-label, Randomized, Two-sequence Study Evaluating the Effect of CYP3A4 Inhibition on the Pharmacokinetics, Safety and Tolerability of Lu AG06466 in Healthy Men and Women
Conditions
Interventions
Lu AG06466
Itraconazole
Locations
1
United States
US1517
Miami, Florida, United States
Start Date
May 20, 2020
Primary Completion Date
July 28, 2020
Completion Date
July 28, 2020
Last Updated
August 14, 2020
NCT00104325
NCT07470866
NCT06637865
NCT07388667
NCT07221448
NCT07118891
Lead Sponsor
H. Lundbeck A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions